Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19

contractpharmaApril 28, 2020

Tag: CTI BioPharma , COVID-19 , PRE-VENT , Pacritinib

PharmaSources Customer Service